Bayer Canada partners with Mint Pharma for distribution of ADALAT XL 30 mg tablets in Canada
Mississauga: Bayer Canada has announced a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT XL 30 mg tablets in Canada. This strategic collaboration took effect on September 3, 2025.
“We are excited to partner with Mint Pharmaceuticals Inc., a company known for its commitment to quality and customer service,” said Viktoria Friedrich, Country President and General Manager at Bayer Inc., Pharmaceutical Division. “This partnership will enable us to leverage Mint’s extensive distribution network and expertise in the Canadian market, ensuring that ADALAT XL remains readily available to those who need it.”
Mint Pharmaceuticals is a Canadian-owned and operated manufacturer of affordable generic medicines.
In 2024, Mint launched its 100th molecule in Canada. The company has been recognized by Deloitte as one of Canada’s Best Managed Companies for seven consecutive years, achieving Platinum Club status in 2025, and is a member company of the Canadian Generic Pharmaceutical Association (CGPA).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.